Haven't used Doza yet?
Ask Trustburn

Questions about Doza

Based on 5 reviews, listing data and website checks · updated 4 days ago

What is Doza?

Doza is an iPhone application designed to help users track their GLP-1 injection treatment, such as Wegovy, Mounjaro, and Ozempic. It provides weekly injection reminders, an estimated curve of medication levels based on published half-lives, and weight tracking with percentage loss since the starting weight. The app is specifically designed for the French healthcare journey to help users prepare for medical consultations by keeping injection history and weight evolution up to date.

What are the pricing plans and subscription terms?

The app offers a lifetime access option with a single purchase or a monthly subscription without commitment. Users can choose their injection day and time, and the app sends a weekly reminder with a quick action to record the injection without opening the app. There is no calorie counting or stock management required as the journal updates automatically in two gestures.

Which countries or markets does Doza specifically serve?

Doza is designed for the French healthcare journey and includes a feature related to the official French reimbursement milestone of 5% weight loss at around 4 to 6 months. It helps users prepare for medical consultations by keeping injection history and weight evolution up to date. The app also includes a guide on the official French reimbursement conditions for 2026, including IMC and nutritional pathways.

What specific features does the app offer for tracking medication levels?

Users can visualize their treatment through an estimated curve that shows the rise, peak, and decline of medication levels in the body based on published half-lives. This curve is purely informative and not a medical measurement, but it helps users know where they are in their week. The app also allows users to note their effects after each injection and review them day by day.

How does Doza assist with the French reimbursement process?

The app helps users arrive prepared for their 6-month evaluation appointment in France, where the HAS sets a reference of 5% weight loss. Doza tracks this repère with the user, providing purely informative sources and allowing them to show their numbers during the consultation. This feature is particularly useful for meeting the official French reimbursement requirements.

What guidance does the app provide for missed injections and injection sites?

The app includes a guide on what to do if an injection is missed, detailing the steps for each day. It also provides guidance on changing the injection day and specifies the injection sites as the belly, thigh, or arm. These practical guides are part of the essential features offered to manage the treatment effectively.

How does the app handle side effect tracking?

The app allows users to note their effects after each injection and retrieve them day by day in their journal. This feature helps users track how their body responds to the medication over time. It is designed to be simple, requiring only two gestures to maintain the journal.

How does Doza compare to other health tracking apps?

The app's website states that it is designed for the French healthcare journey and helps users prepare for medical consultations. It is specifically tailored to the French system, including the 5% weight loss milestone. The app is available on the App Store under the name 'Doza : Suivi GLP-1 & Poids'.

What are the key steps for using the app?

The app provides a weekly reminder with a quick action to record the injection without opening the app. It also offers a guide on changing the injection day and specifies the injection sites as the belly, thigh, or arm. These features are designed to simplify the treatment process.

What is the official website of Doza?

The official website of Doza is dozaglp1.com.

How is Doza rated on Trustburn?

On Trustburn, Doza has a rating of 4.2 out of 5 based on 5 reviews.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Julien Moreau
Reviews 1

Doza propose un suivi du poids et des rappels d’injection pour les traitements GLP-1. Les données restent sur l’appareil sans création de compte. La courbe est indicative. L’application semble utile pour préparer les consultations médicales avec un historique clair et privé.

Sophie Lemaire
Reviews 1

L’application Doza répond précisément aux besoins de suivi des traitements GLP-1. La fonctionnalité de rappel hebdomadaire est particulièrement bien conçue : on peut confirmer l’injection en un seul geste sans même ouvrir l’interface. La courbe visuelle permet de suivre la montée, le pic et la décroissance du médicament, bien qu’il s’agisse d’une estimation informative. Ce suivi aide à arriver préparé chez le médecin, avec l’historique des injections et l’évolution du poids toujours à jour. L’approche privée est un vrai plus : aucune inscription n’est obligatoire, les données restent sur l’iPhone et il n’y a ni publicité ni traceurs. Le site est également cohérent avec cette philosophie, sans cookies ni mesure d’audience. Pour ceux qui souhaitent gérer leur traitement sans complexité ni partage excessif de données, c’est une solution élégante et rassurante. Le guide sur le remboursement et les conditions 2026 est aussi un atout informatif précieux.

Lucas Martin
Reviews 1

Doza se distingue par son approche centrée sur la vie privée. Aucune création de compte n’est nécessaire, et les données restent sur l’iPhone, sans envoi vers des serveurs externes. Cette conception garantit que vos mesures de poids et vos doses ne quittent jamais votre appareil. L’application propose des rappels d’injection personnalisables et une courbe estimant le niveau de médicament dans l’organisme. Bien que cette courbe soit basée sur des modèles mathématiques et non sur des mesures médicales directes, elle offre une vue d’ensemble utile pour préparer les consultations médicales. Le suivi du pourcentage de perte par rapport au poids initial est également un atout majeur. Enfin, l’absence de publicité et de traceurs renforce la confidentialité. C’est un outil numérique efficace pour ceux qui souhaitent garder le contrôle de leur parcours de traitement sans partager excessivement leurs données avec des tiers.

Claire Valentin
Reviews 1

L’interface est claire et le suivi du poids est bien pensé. Attention, la courbe reste une estimation informative, pas une mesure médicale précise.

Marc Dubois
Reviews 1

L’application offre un suivi GLP-1 très utile avec rappels et courbes estimées. Le tarif s’affiche avant la souscription, ce qui est rassurant. Cependant, le détail des fonctionnalités payantes reste à vérifier dans l’offre. Pour qui cherche à organiser son traitement sans surcharge, c’est une solution élégante et privative.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="dozaglp1-com" data-lang="en"></div>
More widgets

About Doza

Doza is a mobile application designed to help users track their GLP-1 injection treatment. It provides weekly injection reminders, an estimated curve of medication levels in the body based on published half-lives, and weight tracking with percentage loss since the starting weight. The app is designed for the French healthcare journey and helps users prepare for medical consultations by keeping their injection history and weight evolution up to date. It also includes a feature related to the official French reimbursement milestone of 5% weight loss at around 4 to 6 months. The app emphasizes privacy by design, stating that measurements and doses remain on the user's iPhone, and offers a 14-day free trial.